Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
Annals of Surgery|October 9, 2002
Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodesDonald L Morton, Eddy C Hsueh, Richard Essner, et al.Chest|July 22, 2008
High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung diseaseJonathan G Goldin, David A Lynch, Diane C Strollo, et al.Plos One|July 8, 2017
The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantationMichael Y Shino, S Samuel Weigt, Ning Li, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 25, 2019
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18Elizabeth R Volkmann, Donald P Tashkin, Masataka Kuwana, et al.Annals of the Rheumatic Diseases|November 10, 2018
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohortsElizabeth R Volkmann, Donald P Tashkin, Myung Sim, et al.Annals of Surgical Oncology|December 22, 2019
Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal DiseaseAbhineet Uppal, Stacey Stern, John F Thompson, et al.Plos One|November 21, 2018
Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosisAnna-Maria Hoffmann-Vold, Stephen Samuel Weigt, Vyacheslav Palchevskiy, et al.Journal of the National Cancer Institute|December 21, 2006
Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition StudyRowan T Chlebowski, George L Blackburn, Cynthia A Thomson, et al.Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2020
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung DiseaseShervin Assassi, Ning Li, Elizabeth R Volkmann, et al.Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancerEdward B Garon, Jill M Siegfried, Laura P Stabile, et al.Pageof 8